# DBS System

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dbs-system

- Industry: Medical Devices & Equipment
- Headquarters: Switzerland
- Website: www.dbs-system.ch
- Total disclosed funding: $2.5M
- Latest round: Series A (May 3, 2017)
- Investors on record: 2

## About

DBS System SA is a Swiss company specializing in innovative micro blood sampling solutions, focusing on enhancing the ease and accessibility of blood collection for clinical applications.Founded in 2010 in Switzerland, DBS System SA offers advanced micro blood sampling solutions. The company has received Series A funding of CHF 2.5 million in May 2017, led by Investiere.ch, with additional participation from the Nest Collective Foundation. The firm has successfully completed 1 deal, reflecting its potential in the medical technology sector. The CEO, Eric Ödman, has not been reported to have founded other companies prior to this venture.DBS System SA specializes in micro blood sampling solutions, notably through its HemaXis DB10 device. This platform allows for the collection of whole blood, plasma, and serum samples with minimal invasiveness, utilizing microfluidic technology to eliminate the need for traditional blood tubes and cold storage. The HemaXis DB10 is designed for convenience, facilitating blood sampling anywhere without the intimidation of needles. Key applications include therapeutic drug monitoring and clinical chemistry tests, serving clients in clinical laboratories and pharmaceutical companies across Europe and the United States.DBS System SA generates revenue through sales of its HemaXis DB10 micro blood sampling devices to clinical labs and healthcare providers. The sales are typically conducted on a B2B basis, integrating into laboratory workflows to enhance blood sampling and analysis efficiency. The pricing structure reflects the innovative technology, aiming for cost savings by reducing the logistics of traditional blood sampling.DBS System SA plans to leverage the CHF 2.5 million raised in its Series A funding to accelerate product development and market entry. The company aims to introduce new products enhancing its micro blood sampling technology in the coming years. Additionally, DBS System SA is focusing on expanding its presence in markets across Europe and potentially into emerging regions, targeting specific geographic areas for growth by 2024. This strategic approach is designed to enhance their market footprint and meet increasing demand in the healthcare sector.

## Funding rounds

- Series A, May 3, 2017, $2.5M — Verve Ventures, Nest Collective Foundation

## Investors

- Verve Ventures (https://capitalatlas.ai/funds/verve-ventures) — Series A
- Nest Collective Foundation (https://capitalatlas.ai/funds/nest-collective-foundation) — Series A